Cypress Capital’s CVS Health CVS Stock Holding History

Cypress Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-78	Closed	-$4.61K	–	150
2024 Q2	$4.61K	Buy	+78	New	+$4.88K	﹤0.01%	238
2022 Q3	–	Sell	-7,771	Closed	-$720K	–	109
2022 Q2	$720K	Sell	7,771 -8	-0.1%	-$781	0.1%	122
2022 Q1	$787K	Sell	7,779 -315	-4%	-$33.1K	0.1%	126
2021 Q4	$835K	Buy	8,094 +263	+3%	+$24.3K	0.1%	124
2021 Q3	$665K	Buy	7,831 +7,821	+78,210%	+$655K	0.08%	128
2021 Q2	$1K	Hold	10	–	–	﹤0.01%	72
2021 Q1	$1K	Hold	10	–	–	﹤0.01%	95
2020 Q4	$1K	Buy	+10	New	+$650	﹤0.01%	86
2020 Q3	–	Sell	-15,942	Closed	-$1.04M	–	64
2020 Q2	$1.04M	Buy	+15,942	New	+$1M	0.46%	41
2019 Q4	$965K	Buy	12,996 +632	+5%	+$44.4K	0.41%	35
2019 Q3	$780K	Buy	12,364 +1,038	+9%	+$61.5K	0.36%	47
2019 Q2	$617K	Buy	11,326 +677	+6%	+$36.5K	0.28%	54
2019 Q1	$574K	Buy	+10,649	New	+$657K	0.24%	59

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cypress Capital's CVS Position: Q3 2024 in Review

Cypress Capital sold out of CVS Health (CVS) in Q3 2024, closing a stake of 78 shares — an estimated $4.61K sold.

Cypress Capital first reported a position in CVS in Q1 2019 and held it in 13 quarters. The position peaked at $1.04M in Q2 2020. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

Cypress Capital reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
Cypress Capital sold 78 CVS Health shares in Q3 2024, an estimated $4.61K.
Cypress Capital first reported a position in CVS Health in Q1 2019 and held it in 13 quarters.
Cypress Capital's CVS Health position peaked at $1.04M in Q2 2020.
1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Cypress Capital's 13F filing for Q3 2024, filed 12 Nov 2024.